Quantcast

Latest Percutaneous coronary intervention Stories

2014-09-16 08:29:53

-- Differentiated Design Yields Excellent Tissue Healing and Sustained Safety Profile -- DURHAM, N.C., Sept. 16, 2014 /PRNewswire/ -- Micell Technologies, Inc. today announced that three-year clinical results from the DESSOLVE I and DESSOLVE II trials of its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES(®)) were presented at the 26th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference being held in Washington, D.C., September 13-17....

2014-09-15 23:08:28

ChinaMarketResearchReports.com adds Latest Report on “China PTCA Balloon Market Investment Report, 2014-2016” to its store. Inquire before buying on this report at http://www.chinamarketresearchreports.com/contacts/inquire-before-buy.php?name=114907 Dallas, TX (PRWEB) September 15, 2014 PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations....

2014-09-15 12:28:28

- The ENDURE Trial to assess efficacy of the novel Drug Coated Chocolate® PTA (Chocolate® Touch) SINGAPORE, Sept. 15, 2014 /PRNewswire/ -- Catalist-listed QT Vascular Ltd. ("QT Vascular" or together with its subsidiaries, "the Group"), a developer and manufacturer of minimally invasive medical devices for the treatment of vascular diseases, is pleased to announce that the Group has enrolled the first European patients in the ENDURE Trial in Germany. Multiple patients have...

2014-09-15 12:26:57

- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device used in the heart that functions like a stent but dissolves over time ABBOTT PARK, Ill., Sept. 15, 2014 /PRNewswire/ -- Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent. Absorb is the...

2014-08-21 23:09:14

The North American interventional cardiology devices market study covers the surgical and diagnostic devices market for angioplasty, aneurysm repair, and deep vein thrombosis procedures (http://www.marketsandmarkets.com/Market-Reports/north-american-interventional-cardiology-peripheral-vascular-devices-market-138691746.html). (PRWEB) August 21, 2014 The "North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting),...

2014-08-19 04:22:48

Companies Reach Agreement to Develop a New and Differentiated FFR Guidewire and Next Generation Boston Scientific Rotablator(TM) RotaWire(TM) MARLBOROUGH, Mass. and NAGOYA, Japan, Aug. 19, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and ASAHI INTECC (Securities Code 7747, Second Section, Tokyo and Nagoya Stock Exchange) have formalized plans to develop a new, differentiated fractional flow reserve (FFR) wire. The joint project focuses on creating a device intended...

2014-08-13 23:10:27

University of Pittsburgh Medical Center East (UPMC East) Receives ACE Accreditation, Approved by the Exceptions Committee of the Commonwealth of Pennsylvania Washington, DC (PRWEB) August 13, 2014 The exceptions committee from the Commonwealth of Pennsylvania has announced its approval of the UPMC East application to perform elective PCI without onsite open heart surgery for their cardiac catheterization lab. The decision by the Commonwealth to provide the exception was based, in part, on...

2014-08-13 08:26:49

SAN DIEGO, Aug. 13, 2014 /PRNewswire/ -- Cardium Therapeutics, an operating unit of Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) today announced the publication of a review article in the Journal of Cardiovascular Pharmacology that concludes a gene therapy product promoting the growth of blood vessels is "highly warranted" to treat about 1 million U.S. heart-disease patients and 6 million more worldwide who are either ineligible or poor candidates for traditional...

2014-08-06 16:29:23

PLEASANTON, Calif., Aug. 6, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that its CE Mark Clinical Trial for HeartMate PHP(TM) (Percutaneous Heart Pump) has commenced. "We are excited to begin the CE Mark Clinical Trial for HeartMate PHP and look forward to successful execution of this important clinical study," said Gary F. Burbach, President and...

heart attack timing
2014-07-31 04:00:24

American Heart Association Rapid Access Journal Report Going to the hospital for a heart attack during evenings, weekends and holidays increases your risk of dying 13 percent compared with people arriving during workday hours, according to new research in the American Heart Association journal Circulation: Cardiovascular Quality and Outcomes. Every year, more than 250,000 people experience an ST elevation myocardial infarction (STEMI), the most severe type of heart attack caused by a...


Latest Percutaneous coronary intervention Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »
Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related